Effectiveness of Pulmonary Rehabilitation in Interstitial Lung Disease, Including Coronavirus Diseases: A Systematic Review and Meta-analysis.

The trials could not be split by what the exercise programme contained. Some were exercise only, others combined aerobic work with strength training, respiratory muscle training or education, so no single component can be credited with the improvement. Intensity, duration and frequency varied between programmes and were often missing or reported inconsistently, so the review cannot say what dose works. Most trials (72.7%) were rated as having 'some concerns' for risk of bias and 18.2% as high risk; 91% gave no clear account of whether their reported results were chosen in advance. The pooled results mix different types of interstitial lung disease, and how severe people's disease was at the start was not available in most studies, so it is unclear whether severity changes the effect. Lung function was measured in only 3 of the 11 trials, so that result rests on a small amount of data. Quality of life could only be pooled from total questionnaire scores, so physical and mental sub-scores were not examined and may behave differently. People with mild to moderate COVID-19 were deliberately excluded, so the post-coronavirus findings apply to those hospitalised with lung lesions.

The article text provided contains no funding statement or conflict-of-interest declaration.

Do not assume pulmonary rehabilitation fixes breathlessness. That outcome was not statistically significant and the trials disagreed about its direction, even though the paper's overall conclusion sounds positive. The quality-of-life gain of 3.9 points also fell below the threshold the authors themselves call a minimum important difference, so the significant pooled figure overstates what patients would feel.